Yo-ichi Takei, MD; Shu-ichi Ikeda, MD; Yasuhiko Hashikura, MD; Toshihiko Ikegami, MD; Seiji Kawasaki, MD
Grant Support: In part by a research grant from the Intractable Disease Division, Ministry of Health and Welfare, Primary Amyloidosis Research Committee, Japan; a group research grant for the pathogenesis and therapy for hereditary neuropathy (10B-3); and a Grant-in-Aid for Scientific Research, Ministry of Education, Science and Culture, Japan (07457124).
Requests for Reprints: Shu-ichi Ikeda, MD, Department of Medicine, Neurology, Shinshu University School of Medicine, Matsumoto 390-8621, Japan; e-mail, email@example.com.
Current Author Addresses: Drs. Takei and Ikeda: Department of Medicine, Neurology, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
Drs. Hashikura, Ikegami, and Kawasaki: Department of Surgery, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
Recently, liver transplantation has been used to treat patients with familial amyloid polyneuropathy (FAP).
To describe the clinical course of patients with FAP who received partial-liver transplantation from living donors.
University hospital in Matsumoto, Japan.
11 patients with FAP who underwent partial-liver transplantation. The transthyretin gene abnormality in all 11 patients was the substitution of methionine for valine at position 30.
Partial liver transplantation from living donors.
Preoperative and follow-up (3 to 64 months) clinical data, including routine laboratory data, nerve conduction velocity tests, and sural nerve histology.
All 7 patients who had severe gastrointestinal autonomic disorders or polyneuropathy localized to the lower limbs for less than 4 years showed improvement. Three of 4 patients with polyneuropathy involving both the upper and lower limbs had adverse outcomes, including two deaths. The preoperative duration of their illness was more than 6 years. These 3 patients also had marked decreases in creatinine clearance and nerve conduction velocities and severe loss of myelinated fibers in sural nerves.
Preoperative clinical severity and duration of illness are associated with outcomes after liver transplantation for FAP.
Takei Y, Ikeda S, Hashikura Y, et al. Partial-Liver Transplantation To Treat Familial Amyloid Polyneuropathy: Follow-up of 11 Patients. Ann Intern Med. 1999;131:592–595. doi: https://doi.org/10.7326/0003-4819-131-8-199910190-00008
Download citation file:
Published: Ann Intern Med. 1999;131(8):592-595.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use